ZFIN ID: ZDB-PUB-190624-9
Phenotyping an adult zebrafish lamp2 cardiomyopathy model identifies mTOR inhibition as a candidate therapy
Dvornikov, A.V., Wang, M., Yang, J., Zhu, P., Le, T., Lin, X., Cao, H., Xu, X.
Date: 2019
Source: Journal of Molecular and Cellular Cardiology   133: 199-208 (Journal)
Registered Authors: Lin, Xueying, Xu, Xiaolei, Yang, Jingchun, Zhu, Ping
Keywords: Cardiac contractility, Cardiomyopathy, Danon disease, Disease modeling, Hypertrophic remodeling, Single myofibril, Zebrafish, mTOR
MeSH Terms:
  • Animals
  • Cardiomegaly/genetics
  • Disease Models, Animal
  • Gene Knockout Techniques
  • Glycogen Storage Disease Type IIb/genetics
  • Glycogen Storage Disease Type IIb/metabolism*
  • Lysosomal-Associated Membrane Protein 2/genetics*
  • Lysosomal-Associated Membrane Protein 2/metabolism
  • Myocardial Contraction/genetics
  • Myocardium/metabolism
  • Myofibrils/metabolism
  • Phenotype*
  • Receptors, Adrenergic, beta/metabolism
  • Stroke Volume
  • TOR Serine-Threonine Kinases/antagonists & inhibitors*
  • TOR Serine-Threonine Kinases/genetics
  • TOR Serine-Threonine Kinases/metabolism
  • Ventricular Remodeling/genetics
  • Zebrafish/genetics*
  • Zebrafish/metabolism
PubMed: 31228518 Full text @ J. Mol. Cell. Cardiol.
Adult zebrafish is an emerging vertebrate model for studying genetic basis of cardiomyopathies; but whether the simple fish heart can model essential features of hypertrophic cardiomyopathy (HCM) remained unknown. Here, we report a comprehensive phenotyping of a lamp2 knockout (KO) mutant. LAMP2 encodes a lysosomal protein and is a causative gene of Danon disease that is characterized by HCM and massive autophagic vacuoles accumulation in the tissues. There is no effective therapy yet to treat this most lethal cardiomyopathy in the young. First, we did find the autophagic vacuoles accumulation in cardiac tissues from lamp2 KO. Next, through employing a set of emerging phenotyping tools, we revealed heart failure phenotypes in the lamp2 KO mutants, including decreased ventricular ejection fraction, reduced physical exercise capacity, blunted β-adrenergic contractile response, and enlarged atrium. We also noted changes of the following indices suggesting cardiac hypertrophic remodeling in lamp2 KO: a rounded heart shape, increased end-systolic ventricular volume and density of ventricular myocardium, elevated actomyosin activation kinetics together with increased maximal isometric tension at the level of cardiac myofibrils. Lastly, we assessed the function of lysosomal-localized mTOR on the lamp2-associated Danon disease. We found that haploinsufficiency of mtor was able to normalize some characteristics of the lamp2 KO, including ejection fraction, β-adrenergic response, and the actomyosin activation kinetics. In summary, we demonstrate the feasibility of modeling the inherited HCM in the adult zebrafish, which can be used to develop potential therapies.